{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:25:26Z","timestamp":1793755526739,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Vice chancellor for research, Shahid Beheshti University of Medical Sciences.","award":["IR.SBMU.MSP.REC.1396.230"],"award-info":[{"award-number":["IR.SBMU.MSP.REC.1396.230"]}],"id":[{"id":"https:\/\/ror.org\/034m2b326","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Our study compare the short and long-term efficacy of the intra articular injections (IAIs) of hyaluronic acid (HA), platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), and ozone in patients with knee osteoarthritis (OA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this randomized clinical trial, 238 patients with mild to moderate knee OA were randomized into 4 groups of IAIs: HA (3 doses weekly), PRP (2 doses with 3\u2009weeks interval), PRGF (2 doses with 3\u2009weeks interval), and Ozone (3 doses weekly). Our outcome measures were the mean changes from baseline (immediately from the first injections) until 2,6, and 12\u2009months post intervention in scores of visual analog scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Lequesne index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 200 patients enrolled in the final analysis. The mean age of patients was 56.9\u2009\u00b1\u20096.3\u2009years, and 69.5% were women. In 2\u2009months follow up, significant improvement of pain, stiffness, and function were seen in all groups compared to the baseline, but the ozone group had the best results (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). In 6\u2009month follow up HA, PRP, and PRGF groups demonstrated better therapeutic effects in all scores in comparison with ozone (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). At the end of the 12th month, only PRGF and PRP groups had better results versus HA and ozone groups in all scores (P\u2009&lt;\u20090.05). Despite the fact that ozone showed better early results, its effects begin to wear off earlier than other products and ultimately disappear in 12\u2009months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ozone injection had rapid effects and better short-term results after 2\u2009months, but its therapeutic effects did not persist after 6\u2009months and at the 6-month follow up, PRP,PRGF and HA were superior to ozone. Only patients in PRP and PRGF groups improved symptoms persisted for 12\u2009months. Therefore, these products could be the preferable choices for long-term management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Registered in the Iranian Center of Clinical Trials (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.irct.ir\">www.irct.ir<\/jats:ext-link>\n                      ) in 11\/11\/2017 with the following code: IRCT2017082013442N17.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-021-04017-x","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T12:03:13Z","timestamp":1612353793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":154,"title":["The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Seyed Ahmad","family":"Raeissadat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parsa","family":"Ghazi Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hasan","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Salman Roghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Gharooee Ahangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Darvish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"issue":"3","key":"4017_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00402-010-1167-3","volume":"131","author":"A Wang-Saegusa","year":"2011","unstructured":"Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cusc\u00f3 X, Garcia-Balletb\u00f3 M. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg. 2011;131(3):311\u20137.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"3","key":"4017_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.reumae.2012.05.006","volume":"9","author":"J De La Mata","year":"2013","unstructured":"De La Mata J. Platelet rich plasma. A new treatment tool for the rheumatologist? Reumatolog\u00eda Cl\u00ednica (English Edition). 2013;9(3):166\u201371.","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"key":"4017_CR3","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2147\/JPR.S169613","volume":"11","author":"SA Raeissadat","year":"2018","unstructured":"Raeissadat SA, Rayegani SM, Sedighipour L, Bossaghzade Z, Abdollahzadeh MH, Nikray R, Mollayi F. The efficacy of electromyographic biofeedback on pain, function, and maximal thickness of vastus medialis oblique muscle in patients with knee osteoarthritis: a randomized clinical trial. J Pain Res. 2018;11:2781.","journal-title":"J Pain Res"},{"issue":"1","key":"4017_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheumatism. 2008;58(1):26\u201335.","journal-title":"Arthritis Rheumatism"},{"issue":"4","key":"4017_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/1756-185X.12312","volume":"17","author":"A Tehrani-Banihashemi","year":"2014","unstructured":"Tehrani-Banihashemi A, Davatchi F, Jamshidi AR, Faezi T, Paragomi P, Barghamdi M. Prevalence of osteoarthritis in rural areas of I ran: a WHO-ILAR COPCORD study. Int J Rheum Dis. 2014;17(4):384\u20138.","journal-title":"Int J Rheum Dis"},{"issue":"Suppl 1","key":"4017_CR6","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.15171\/jlms.2017.s3","volume":"8","author":"SM Rayegani","year":"2017","unstructured":"Rayegani SM, Raeissadat SA, Heidari S, Moradi-Joo M. Safety and effectiveness of low-level laser therapy in patients with knee osteoarthritis: a systematic review and meta-analysis. J Lasers Med Sci. 2017;8(Suppl 1):S12.","journal-title":"J Lasers Med Sci"},{"issue":"3","key":"4017_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3810\/psm.2012.09.1976","volume":"40","author":"GD Deyle","year":"2012","unstructured":"Deyle GD, Gill NW. Well-tolerated strategies for managing knee osteoarthritis: a manual physical therapist approach to activity, exercise, and advice. Phys Sportsmed. 2012;40(3):12\u201325.","journal-title":"Phys Sportsmed"},{"issue":"11","key":"4017_CR8","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru RR, Osani M, Vaysbrot E, Arden N, Bennell K, Bierma-Zeinstra S, Kraus V, Lohmander L, Abbott J, Bhandari M. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27(11):1578\u201389.","journal-title":"Osteoarthr Cartil"},{"issue":"7","key":"4017_CR9","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.17.00167","volume":"6","author":"C Vannabouathong","year":"2018","unstructured":"Vannabouathong C, Bhandari M, Bedi A, Khanna V, Yung P, Shetty V, Khan M. Nonoperative treatments for knee osteoarthritis: an evaluation of treatment characteristics and the intra-articular placebo effect: a systematic review. Jbjs Rev. 2018;6(7):e5.","journal-title":"Jbjs Rev"},{"key":"4017_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.toxicon.2019.04.003","volume":"165","author":"S Najafi","year":"2019","unstructured":"Najafi S, Sanati E, Khademi M, Abdorrazaghi F, Mofrad RK, Rezasoltani Z. Intra-articular botulinum toxin type a for treatment of knee osteoarthritis: clinical trial. Toxicon. 2019;165:69\u201377.","journal-title":"Toxicon"},{"key":"4017_CR11","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.2147\/JPR.S127633","volume":"10","author":"Z Rezasoltani","year":"2017","unstructured":"Rezasoltani Z, Taheri M, Mofrad MK, Mohajerani SA. Periarticular dextrose prolotherapy instead of intra-articular injection for pain and functional improvement in knee osteoarthritis. J Pain Res. 2017;10:1179.","journal-title":"J Pain Res"},{"key":"4017_CR12","first-page":"117954411773345","volume":"10","author":"SA Raeissadat","year":"2017","unstructured":"Raeissadat SA, Rayegani SM, Ahangar AG, Abadi PH, Mojgani P, Ahangar OG. Efficacy of intra-articular injection of a newly developed plasma rich in growth factor (PRGF) versus hyaluronic acid on pain and function of patients with knee osteoarthritis: a single-blinded randomized clinical trial. Clin Med Insights. 2017;10:1179544117733452.","journal-title":"Clin Med Insights"},{"issue":"3","key":"4017_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5312\/wjo.v5.i3.351","volume":"5","author":"E Ayhan","year":"2014","unstructured":"Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5(3):351.","journal-title":"World J Orthop"},{"issue":"10","key":"4017_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.5435\/JAAOS-D-16-00541","volume":"25","author":"EG Matzkin","year":"2017","unstructured":"Matzkin EG, Curry EJ, Kong Q, Rogers MJ, Henry M, Smith EL. Efficacy and treatment response of intra-articular corticosteroid injections in patients with symptomatic knee osteoarthritis. JAAOS-Journal of the American Academy of Orthopaedic Surgeons. 2017;25(10):703\u201314.","journal-title":"JAAOS-Journal of the American Academy of Orthopaedic Surgeons"},{"key":"4017_CR15","first-page":"73","volume":"10","author":"D Webb","year":"2018","unstructured":"Webb D, Naidoo P. Viscosupplementation for knee osteoarthritis: a focus on Hylan GF 20. Orthop Res Rev. 2018;10:73.","journal-title":"Orthop Res Rev"},{"issue":"1","key":"4017_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40169-017-0180-3","volume":"7","author":"S Bowman","year":"2018","unstructured":"Bowman S, Awad ME, Hamrick MW, Hunter M, Fulzele S. Recent advances in hyaluronic acid based therapy for osteoarthritis. Clin Translational Med. 2018;7(1):6.","journal-title":"Clin Translational Med"},{"key":"4017_CR17","first-page":"87","volume":"2","author":"AH Conduah","year":"2009","unstructured":"Conduah AH, Baker CL III, Baker CL Jr. Managing joint pain in osteoarthritis: safety and efficacy of hylan GF 20. J Pain Res. 2009;2:87.","journal-title":"J Pain Res"},{"issue":"2","key":"4017_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/art.41142","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, Callahan L, Copenhaver C, Dodge C, Felson D. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220\u201333.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"4017_CR19","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s10067-019-04597-z","volume":"38","author":"LE Miller","year":"2019","unstructured":"Miller LE. Towards reaching consensus on hyaluronic acid efficacy in knee osteoarthritis. Clin Rheumatol. 2019;38(10):2881\u20133.","journal-title":"Clin Rheumatol"},{"key":"4017_CR20","doi-asserted-by":"crossref","unstructured":"Miller LE, Bhattacharyya S, Parrish WR, Fredericson M, Bisson B, Altman RD. Safety of intra-articular hyaluronic acid for knee osteoarthritis: systematic review and meta-analysis of randomized trials involving more than 8,000 patients. Cartilage. 2019;1947603519888783.","DOI":"10.1177\/1947603519888783"},{"key":"4017_CR21","first-page":"563","volume-title":"Seminars in Arthritis and Rheumatism: 2019: Elsevier","author":"E Maheu","year":"2019","unstructured":"Maheu E, Bannuru RR, Herrero-Beaumont G, Allali F, Bard H, Migliore A. Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review. In: Seminars in Arthritis and Rheumatism: 2019: Elsevier; 2019. p. 563\u201372."},{"issue":"1","key":"4017_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-019-2667-0","volume":"20","author":"Y Henrotin","year":"2019","unstructured":"Henrotin Y, Bannuru R, Malaise M, Ea H-K, Confavreux C, Bentin J, Urbin-Choffray D, Conrozier T, Brasseur J-P, Thomas P. Hyaluronan derivative HYMOVIS\u00ae increases cartilage volume and type II collagen turnover in osteoarthritic knee: data from MOKHA study. BMC Musculoskelet Disord. 2019;20(1):1\u201316.","journal-title":"BMC Musculoskelet Disord"},{"issue":"8","key":"4017_CR23","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1517\/14712598.2013.801450","volume":"13","author":"E Anitua","year":"2013","unstructured":"Anitua E, S\u00e1nchez M, Orive G, Padilla S. A biological therapy to osteoarthritis treatment using platelet-rich plasma. Expert Opin Biol Ther. 2013;13(8):1161\u201372.","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"4017_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12891-018-1963-4","volume":"19","author":"SA Raeissadat","year":"2018","unstructured":"Raeissadat SA, Karimzadeh A, Hashemi M, Bagherzadeh L. Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial. BMC Musculoskelet Disord. 2018;19(1):49.","journal-title":"BMC Musculoskelet Disord"},{"key":"4017_CR25","doi-asserted-by":"crossref","unstructured":"Belk JW, Kraeutler MJ, Houck DA, Goodrich JA, Dragoo JL, McCarty EC. Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Am J Sports Med. 2020;0363546520909397.","DOI":"10.1177\/0363546520909397"},{"issue":"3","key":"4017_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.arthro.2016.09.024","volume":"33","author":"W-L Dai","year":"2017","unstructured":"Dai W-L, Zhou A-G, Zhang H, Zhang J. Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Arthroscopy. 2017;33(3):659\u2013670. e651.","journal-title":"Arthroscopy"},{"issue":"7","key":"4017_CR27","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1177\/0363546515582027","volume":"43","author":"G Filardo","year":"2015","unstructured":"Filardo G, Di Matteo B, Di Martino A, Merli ML, Cenacchi A, Fornasari P, Marcacci M, Kon E. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med. 2015;43(7):1575\u201382.","journal-title":"Am J Sports Med"},{"key":"4017_CR28","doi-asserted-by":"crossref","first-page":"204062231982556","DOI":"10.1177\/2040622319825567","volume":"10","author":"L Gato-Calvo","year":"2019","unstructured":"Gato-Calvo L, Magalhaes J, Ruiz-Romero C, Blanco FJ, Burguera EF. Platelet-rich plasma in osteoarthritis treatment: review of current evidence. Therapeutic Adv Chronic Dis. 2019;10:2040622319825567.","journal-title":"Therapeutic Adv Chronic Dis"},{"issue":"1","key":"4017_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.arthro.2019.05.043","volume":"36","author":"C Sconza","year":"2020","unstructured":"Sconza C, Respizzi S, Virelli L, Vandenbulcke F, Iacono F, Kon E, Di Matteo B. Oxygen\u2013ozone therapy for the treatment of knee osteoarthritis: a systematic review of randomized controlled trials. Arthroscopy. 2020;36(1):277\u201386.","journal-title":"Arthroscopy"},{"key":"4017_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/JPR.S142755","volume":"11","author":"SA Raeissadat","year":"2018","unstructured":"Raeissadat SA, Rayegani SM, Forogh B, Abadi PH, Moridnia M, Dehgolan SR. Intra-articular ozone or hyaluronic acid injection: which one is superior in patients with knee osteoarthritis? A 6-month randomized clinical trial. J Pain Res. 2018;11:111.","journal-title":"J Pain Res"},{"issue":"8","key":"4017_CR31","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/pmrj.12088","volume":"11","author":"PI Arias-V\u00e1zquez","year":"2019","unstructured":"Arias-V\u00e1zquez PI, Tovilla-Z\u00e1rate CA, Hern\u00e1ndez-D\u00edaz Y, Gonz\u00e1lez-Castro TB, Ju\u00e1rez-Rojop IE, L\u00f3pez-Narv\u00e1ez ML, Bermudez-Oca\u00f1a DY, Barjau-Madr\u00edgal HA, Legorreta-Ram\u00edrez G. Short-term therapeutic effects of ozone in the Management of Pain in knee osteoarthritis: a meta-analysis. Pm&r. 2019;11(8):879\u201387.","journal-title":"Pm&r"},{"key":"4017_CR32","volume-title":"Classifications in brief: Kellgren-Lawrence classification of osteoarthritis. In: Springer","author":"MD Kohn","year":"2016","unstructured":"Kohn MD, Sassoon AA, Fernando ND. Classifications in brief: Kellgren-Lawrence classification of osteoarthritis. In: Springer; 2016."},{"issue":"7","key":"4017_CR33","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/14656566.2020.1732924","volume":"21","author":"P Cao","year":"2020","unstructured":"Cao P, Li Y, Tang Y, Ding C, Hunter DJ. Pharmacotherapy for knee osteoarthritis: current and emerging therapies. Expert Opin Pharmacother. 2020;21(7):797\u2013809.","journal-title":"Expert Opin Pharmacother"},{"key":"4017_CR34","doi-asserted-by":"crossref","unstructured":"Whittaker JL, Truong LK, Dhiman K, Beck C: Osteoarthritis year in review 2020: Rehabilitation and outcomes. Osteoarthr Cartil 2020.","DOI":"10.1016\/j.joca.2020.10.005"},{"key":"4017_CR35","first-page":"CMAMD. S17894","volume":"8","author":"SA Raeissadat","year":"2015","unstructured":"Raeissadat SA, Rayegani SM, Hassanabadi H, Fathi M, Ghorbani E, Babaee M, Azma K. Knee osteoarthritis injection choices: platelet-rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial). Clin Med Insights. 2015;8:CMAMD. S17894.","journal-title":"Clin Med Insights"},{"key":"4017_CR36","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.2147\/JPR.S175441","volume":"11","author":"SA Raeissadat","year":"2018","unstructured":"Raeissadat SA, Tabibian E. Raysss efficacy of intra-articular ozone (O2\u2013O3) injection in patients with knee osteoarthritis: a systematic review and meta-analysis. J Pain Res. 2018;11:2537.","journal-title":"J Pain Res"},{"issue":"2","key":"4017_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3233\/BMR-181301","volume":"32","author":"B Dernek","year":"2019","unstructured":"Dernek B, Kesiktas FN. Efficacy of combined ozone and platelet-rich-plasma treatment versus platelet-rich-plasma treatment alone in early stage knee osteoarthritis. J Back Musculoskeletal Rehab. 2019;32(2):305\u201311.","journal-title":"J Back Musculoskeletal Rehab"},{"issue":"3","key":"4017_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ejr.2018.07.005","volume":"41","author":"NM Gaballa","year":"2019","unstructured":"Gaballa NM, Mohammed YA, Kamel LM, Mahgoub HM. Therapeutic efficacy of intra-articular injection of platelet\u2013rich plasma and ozone therapy in patients with primary knee osteoarthritis. Egypt Rheumatol. 2019;41(3):183\u20137.","journal-title":"Egypt Rheumatol"},{"key":"4017_CR39","doi-asserted-by":"crossref","unstructured":"de Sire A, Stagno D, Minetto MA, Cisari C, Baricich A, Invernizzi M. Long-term effects of intra-articular oxygen-ozone therapy versus hyaluronic acid in older people affected by knee osteoarthritis: A randomized single-blind extension study. J Back Musculoskeletal Rehabil. 2020;(Preprint):1\u20138.","DOI":"10.3233\/BMR-181294"},{"issue":"2","key":"4017_CR40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00167-016-4110-5","volume":"25","author":"TM Duymus","year":"2017","unstructured":"Duymus TM, Mutlu S, Dernek B, Komur B, Aydogmus S, Kesiktas FN. Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone options. Knee Surg Sports Traumatol Arthrosc. 2017;25(2):485\u201392.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"4017_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/JPR.S204788","volume":"13","author":"SA Raeissadat","year":"2020","unstructured":"Raeissadat SA, Ghorbani E, Sanei Taheri M, Soleimani R, Rayegani SM, Babaee M, Payami S. MRI changes after platelet rich plasma injection in knee osteoarthritis (randomized clinical trial). J Pain Res. 2020;13:65\u201373.","journal-title":"J Pain Res"},{"issue":"10","key":"4017_CR42","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00167-011-1837-x","volume":"20","author":"G Filardo","year":"2012","unstructured":"Filardo G, Kon E, Ruiz MTP, Vaccaro F, Guitaldi R, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single-versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012;20(10):2082\u201391.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"4","key":"4017_CR43","doi-asserted-by":"publisher","first-page":"FSO231","DOI":"10.4155\/fsoa-2017-0045","volume":"3","author":"SA Raeissadat","year":"2017","unstructured":"Raeissadat SA, Babaee M, Rayegani SM, Hashemi Z, Hamidieh AA, Mojgani P, Vanda HF. An overview of platelet products (PRP, PRGF, PRF, etc.) in the Iranian studies. Future Sci OA. 2017;3(4):FSO231.","journal-title":"Future Sci OA"},{"key":"4017_CR44","unstructured":"Stefano L, Paolo L, Russo S. Knee OA management: a cost-effectiveness analysis of platelet-rich-plasma versus hyaluronic acid for the intra-articular treatment of knee OA in France. Int J Clin Rheumatol. 2018;307."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04017-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-021-04017-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04017-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T12:05:17Z","timestamp":1612353917000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04017-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4017"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04017-x","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"6 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by Shahid Beheshti University of Medical Sciences\u2019 ethical community with the following code: IR.SBMU.MSP.REC.1396.230 and written consent was acquired from candidates and they were allowed to leave the study any time that they wanted. The authors of the present study are committed to CONSORT guidelines in reporting the results.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"134"}}